ABX Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC)
NCT02546934
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
254
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
ABX, cisplatin
DRUG:
Gemcitabine, Cisplatin
Sponsor
Fudan University